Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Wayland Group Corp MRRCF

Wayland Group Corp, formerly Maricann Group Inc produces and sells medical marijuana. It is currently engaged in cultivation, extraction, analytics and production facilities to elevate offerings and prepare for growth into the adult-use cannabis market in Canada.


GREY:MRRCF - Post by User

Bullboard Posts
Post by GeneralAladeenon Mar 28, 2019 1:38pm
168 Views
Post# 29549431

Case to be LONG and not short

Case to be LONG and not short Whether you like it or not - Ben Ward gets a lot of shite done. More than any other small - mid cap cap grower (and a few of the large caps) by a long shot.  Only issue with Ben is his dumb guidance and delays. Every single grower has had the similar problems with missed revenues and delays. We are not alone. 

What we need, is to get thru till Q2-Q3 when real revenue starts rolling in. I think the guidance is purposely conservative to either put it to the shorts or keep the vultures at bay. It is literally impossible with the 7 x 8800 sq ft currently licensed grow rooms and new rooms coming on board to do only $7.7mm in Q3 as per guidance. 

According to my math 8800 sq ft (9000 plants per room) x 7 rooms x 286 grams/ sq ft = 17.6mm grams x $7.50 is over $132mm in annual revenue. Unless they are doing a severe hoarding of pot for EU (which would yield double or triple that amount)  then something is amis. 

Just had another thought about who stands to gain from a ridiculously low share price. Clearly a friendly or hostile acquirer would, shorts would, smart investors buying shares would, but one I hadn’t thought of is .... Alpha Blue. Their convertible debentures can be converted into shares for a period of one year at a VWAP from “time to time”. They get a boatload more shares if our share price is at .85 than at $1.50. 

Ive bought shares at $1.02, .92 and .82. Will continue to add if they drive this down further. By the end of this year we will be in pace to sell $150-$200mm in product with the highest margins in the business. You do the math.... GL 
Bullboard Posts